59 Biggest Movers From Yesterday
Gainers
SeaChange International, Inc. (NASDAQ: SEAC) jumped 128.8% to $1.72 following Bloomberg report suggesting that social video app Triller is in merger talks with Seachange.
40 Stocks Moving In Monday’s Mid-Day Session
Gainers
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.
64 Biggest Movers From Yesterday
Gainers
Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile Electric Vehicle charging solutions for a full range of applications.
Mid-Afternoon Market Update: eHealth Drops Following Q3 Results; Autolus Therapeutics Shares Gain
Toward the end of trading Monday, the Dow traded up 0.12% to 36,372.57 while the NASDAQ rose 0.23% to 16,009.02. The S&P also rose, gaining 0.07% to 4,700.74.
Autolus Stock Rallies On $250M Investment From Blackstone
Blackstone Inc (NYSE:BX) will invest $250 million in Autolus Therapeutics plc (NASDAQ:AUTL) to fund the final stages of developing a new therapy to…
Syncona Announced- Blackstone Life Science to invest $250M in Autolus; Shares of Autolus Up 36% Premarket
Syncona today announced that Blackstone Life Sciences ("Blackstone") has entered into a strategic collaboration and financing agreement with Syncona portfolio company Autolus Therapeutics plc ("Autolus"). The key terms of the financing agreement are set out below:
Autolus Therapeutics Will Present New Data AT American Society Of Hematology Meeting Dec. 11-13
- Demonstrates progress on the Company’s commercial manufacturing process and builds on positive obe-cel clinical data presented at EHA
Conference Call and Webcast to be held Tuesday, December 14, 2021 at
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well
The FDA has sent shockwaves through the off-the-shelf CAR-T space after it slapped a clinical hold
Autolus’ Blood Cancer CAR T-Cell Therapy Receives Promising Innovative Medicine In UK
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted Promising Innovative Medicine (PIM) designation to Autolus Therapeutics plc’s (NASDAQ:AUTL) AUTO1…